Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Korean Journal of Family Medicine ; : 40-42, 2017.
Article in English | WPRIM | ID: wpr-109990

ABSTRACT

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.


Subject(s)
Adult , Female , Humans , Pregnancy , Pregnancy , Amenorrhea , Anxiety Disorders , Citalopram , Depressive Disorder, Major , Hyperprolactinemia , Pregnancy Tests , Pregnancy Tests, Immunologic , Serotonin , Selective Serotonin Reuptake Inhibitors , United States Food and Drug Administration
SELECTION OF CITATIONS
SEARCH DETAIL